Using Consumer Pet DNA Results to Refine Underwriting Risk

Breed has always been one of the strongest predictors of hereditary condition risk in pet insurance underwriting, but breed alone is a blunt instrument. A "Labrador mix" from a shelter intake form could carry anywhere from a small to a substantial share of breeds with very different joint, cardiac, or metabolic risk profiles, and traditional underwriting has no way to tell the difference. Millions of pet owners now have direct-to-consumer DNA test results sitting in an app on their phone that could answer exactly this question. The DNA Test Integration Risk Scoring AI Agent incorporates consumer pet DNA test results into breed-risk and hereditary-condition underwriting models with owner consent. This blog explains how the agent works, how it protects owner consent, how it fits into the underwriting workflow, and the business outcomes it delivers.

The global pet DNA testing market was valued at roughly USD 0.59 billion in 2025 and is projected to keep growing at a compound annual rate of around 9.6 percent, driven by rising direct-to-consumer adoption and growing owner interest in preventive, personalized pet healthcare (natlawreview / Pet DNA Testing Market). North American pet insurance premiums reached roughly USD 5 billion in 2025 (NAPHIA), and as more policyholders arrive already holding a DNA test result, underwriting teams have a growing opportunity, and a growing expectation, to use that data responsibly. Regulators applying the NAIC Model Bulletin on the Use of AI Systems by Insurers increasingly expect any model that incorporates a new class of consumer-provided data to be explainable and consent-driven, which shapes how the agent is designed from the outset.

What Is the DNA Test Integration Risk Scoring AI Agent?

It is an AI system that incorporates consented pet DNA test results into breed-risk and hereditary-condition underwriting models.

1. What Is the Definition and Scope of the DNA Integration Agent?

The agent covers consent capture, DNA data ingestion, genetic marker mapping, and blended risk scoring for underwriting.

The agent only activates for a policy once the owner has explicitly opted to share DNA test results. From that point, it ingests the test provider's breed composition and health marker output, maps the results to known hereditary risk associations, and blends that genetic signal with the carrier's existing underwriting variables to produce a refined risk score for that specific pet.

2. Which Underwriting Elements Does the Agent Evaluate?

The agent evaluates breed composition confidence, hereditary marker presence, marker-to-condition strength of association, and consent status.

Element	Description	Agent Analysis
Breed Composition Confidence	How precisely the test identifies breed mix	Weights genetic breed signal by the provider's reported confidence level
Hereditary Marker Presence	Whether known condition-linked markers are detected	Flags markers associated with conditions like hip dysplasia or cardiomyopathy
Marker-to-Condition Strength	How strongly a marker predicts an actual condition	Applies published strength-of-association data rather than treating every marker as deterministic
Consent Status	Whether the owner has authorized DNA data use	Gates all genetic data processing behind an explicit, revocable consent flag

3. Where Does the Agent Draw Its Source Data From?

The agent draws on consented DNA test provider results, veterinary claims history, and published breed-condition association research.

The agent draws on multiple data sources for its analysis:

DNA testing providers: Breed composition percentages and hereditary health marker results, shared only with owner consent
Claims history: Real-world condition incidence linked to breed and marker profiles across the book of business
Veterinary and genetics research: Published associations between specific markers and hereditary conditions
Policy administration: Existing underwriting variables such as age, breed, and location that the genetic signal supplements

Why Is DNA-Informed Underwriting Important?

It is important because breed alone is an imprecise proxy for hereditary risk, and genetic data can materially sharpen that picture for mixed-breed and purebred pets alike.

1. Why Does Breed-Only Underwriting Leave Risk on the Table?

Breed-only underwriting leaves risk on the table because two pets in the same declared breed category can carry very different actual hereditary risk profiles.

A shelter-adopted dog labeled simply as a "mixed breed" might be underpriced relative to its true risk if it carries a strong genetic predisposition toward a costly condition, or overpriced if it does not, and breed-only underwriting cannot distinguish between the two cases. This is precisely the gap the Mixed Breed Risk Assessment AI Agent is built to close, using DNA results or visual breed identification to estimate a mixed-breed pet's genetic health risk more precisely than a breed label alone.

2. How Does Genetic Data Improve Pricing Precision?

Genetic data improves pricing precision by replacing a population-level breed assumption with an individual pet's actual detected markers where they are available.

This individual-level precision complements the kind of controlled testing done by the Pricing Experiment Design AI Agent, which can measure whether DNA-informed pricing actually improves loss ratio outcomes once rolled out.

Consent has to be central to the design because genetic data is sensitive, and requiring or pressuring DNA testing for coverage would raise fairness and access concerns.

The agent is built so DNA data only ever adds information the owner has voluntarily chosen to share. A pet without shared DNA results is never penalized or treated as higher risk simply for the absence of a test, since that would create backdoor pressure to test.

4. How Does This Support More Accurate Hereditary Condition Coverage?

This supports more accurate hereditary condition coverage decisions by giving underwriters real genetic evidence rather than relying solely on breed-based assumptions about condition likelihood.

That evidence also improves the accuracy of any downstream explanation given to a policyholder about why their pet was priced a certain way, since the explanation can point to an actual detected marker rather than a generic breed statistic.

Turn consented pet DNA data into sharper, fairer underwriting.

Talk to Our Specialists

Visit insurnest to learn how we help carriers integrate genetic data into underwriting responsibly.

How Does the DNA Test Integration Risk Scoring AI Agent Work?

The agent works through a pipeline of consent verification, data ingestion, marker mapping, and blended scoring.

The agent checks for an explicit, current consent flag before it will ingest or process any DNA test result for a policy.

If consent is withdrawn at any point, the agent stops using that pet's genetic data in future scoring and does not retroactively penalize the policy for the withdrawal.

2. How Does the Agent Map DNA Results to Risk Factors?

The agent matches the DNA provider's breed composition and marker output against a maintained library of breed-condition and marker-condition associations.

Rather than building its own genetic research from scratch, the agent applies established, published associations between specific markers or breed compositions and known hereditary conditions, updating the library as new peer-reviewed associations are published. This library draws on the same kind of breed-genetic database screening the Hereditary and Congenital Condition Screening AI Agent already applies to conditions such as hip dysplasia and heart disease.

3. How Does the Agent Blend Genetic Data With Traditional Variables?

The agent combines the genetic signal with existing underwriting variables like age, location, and claims history rather than letting genetic data override them.

This blended approach means a strong genetic marker shifts the risk score meaningfully, but it operates alongside, not instead of, the underwriting factors that already have a proven track record.

4. How Does the Agent Handle Low-Confidence Genetic Signals?

The agent applies conservative weighting to markers with weak or uncertain condition association, preventing a single ambiguous result from swinging a pricing decision.

This keeps the agent from overreacting to a marker that has only a modest published association with a condition, reserving stronger pricing adjustments for markers with well-established links.

5. What Scoring Outcomes Does the Agent Produce?

The agent produces one of four outcomes for each evaluated pet: no genetic adjustment, favorable adjustment, elevated-risk adjustment, or flagged for underwriter review.

Outcome	Criteria	Next Step
No Genetic Adjustment	No DNA data shared, or no relevant markers detected	Standard breed-based underwriting applies
Favorable Adjustment	DNA rules out a suspected hereditary risk	Risk score adjusted downward within approved bounds
Elevated-Risk Adjustment	Strong, well-established hereditary marker detected	Risk score adjusted upward within approved bounds
Flagged for Underwriter Review	Conflicting or unusually rare marker combination	Routed to an underwriter for manual assessment

How Does the Agent Integrate with Existing Systems?

It connects via secure APIs to DNA testing providers, policy administration, and underwriting rating engines.

1. Which Systems Does the Agent Integrate With?

The agent integrates with DNA testing provider platforms, the underwriting rating engine, policy administration, and the claims data warehouse.

System	Integration	Purpose
DNA Testing Providers	Consented API connection	Retrieves breed composition and marker results
Underwriting Rating Engine	API	Supplies the blended genetic risk adjustment for pricing
Policy Administration	API	Stores consent status and links results to the correct pet profile
Claims Data Warehouse	Batch	Supplies historical condition incidence for validating marker associations

2. How Does the Agent Fit into the Underwriting Program?

The agent operates as an optional, consent-gated enrichment layer within the broader underwriting program rather than a mandatory data source.

Its outputs feed the same rating engine used for traditional underwriting, and any adjustment it recommends can be explained back to the policyholder through the same kind of plain-language reasoning the Underwriting Model Explainability AI Agent generates for other underwriting decisions.

3. How Does the Agent Relate to Other Emerging Data Sources in Underwriting?

The agent is one of several emerging, owner-consented data sources being evaluated for underwriting alongside wearable activity data.

Where this agent focuses on static genetic risk, the Wearable-Based Dynamic Pricing AI Agent evaluates ongoing behavioral and activity data, and together the two give carriers a fuller, opt-in picture of a pet's risk profile without requiring either data source.

What Are the Regulatory and Compliance Considerations?

Regulatory considerations include consent documentation, non-discriminatory use of genetic data, and rate filing justification.

Consent documentation matters because regulators and policyholders both need clear evidence that genetic data was shared voluntarily, not required.

The agent logs the exact consent action, timestamp, and scope for every pet whose DNA data it processes, giving compliance teams a defensible record if a regulator or policyholder questions how the data was obtained and used.

2. How Does the Agent Avoid Discriminatory Use of Genetic Data?

The agent avoids discriminatory use by applying the same marker-to-condition logic consistently across all pets and breeds, rather than applying different standards to different populations.

This consistency is a core design principle, since genetic underwriting factors carry a higher fairness risk than traditional factors if applied inconsistently across breed or ownership demographics.

3. What Rate Filing Documentation Supports Genetic Underwriting Factors?

Rate filing documentation should demonstrate that any genetic adjustment is based on statistically supported marker-condition associations and consistently applied.

Actuarial and compliance teams can draw on the agent's marker association library and validation history against claims data to support a rate filing that incorporates genetic risk factors.

4. What AI Governance Expectations Apply to Genetic Underwriting Models?

AI governance expectations require documented model logic, human review for high-impact or unusual cases, and clear consumer disclosure of how genetic data affects pricing.

Consistent with the NAIC Model Bulletin on the Use of AI Systems by Insurers, the agent routes unusual marker combinations to underwriter review and ensures the reasoning behind any genetic adjustment can be explained to the policyholder in plain language.

What Business Outcomes Can Carriers Expect?

Carriers can expect more precise hereditary risk pricing, a new differentiated underwriting capability, and stronger loss ratio accuracy for participating pets.

1. Which Impact Metrics Should Carriers Expect?

Carriers can expect improved pricing precision for pets with shared DNA data, better hereditary condition loss ratio accuracy, and a growing base of genetically informed policies over time.

Metric	Expected Impact
Pricing precision for hereditary conditions	Improved for pets with consented DNA data
Cross-subsidization within breed categories	Reduced as genetic signal supplements breed averages
Hereditary condition loss ratio accuracy	Improved through individual-level risk data
Policyholder DNA data participation	Grows over time as owners see genuine pricing relevance

2. How Does the Agent Support Product Differentiation?

The agent supports product differentiation by giving the carrier a genuinely individualized underwriting capability that owners with DNA-tested pets can see reflected in their pricing.

This can become a meaningful point of distinction for owners who have already invested in genetic testing and want that information to matter in their coverage.

3. Why Does Genetic Precision Strengthen Long-Term Loss Ratio Management?

Genetic precision strengthens long-term loss ratio management because pricing that reflects actual hereditary risk, rather than a breed-level average, reduces the mismatch between premium and expected claims cost.

Over time, as more owners share DNA data, this individual-level accuracy compounds into a meaningfully sharper underwriting book.

Price hereditary risk with the precision genetic data makes possible.

Talk to Our Specialists

Visit insurnest to learn how we help carriers responsibly integrate DNA data into underwriting.

What Are the Limitations and Considerations?

The agent depends on the quality of third-party DNA test data, requires ongoing research updates, and cannot apply to pets without shared genetic data.

1. Why Does the Agent Depend on Third-Party Test Quality?

The agent depends on third-party test quality because its risk mapping is only as reliable as the accuracy of the DNA provider's breed and marker calls.

If a testing provider's methodology changes or a specific marker call proves less reliable than initially understood, the agent's association library needs to be updated accordingly.

2. Why Does the Marker Association Library Require Ongoing Updates?

The marker association library requires ongoing updates because genetic research on hereditary conditions in companion animals continues to evolve.

A marker considered strongly predictive today could be revised as more veterinary genetics research is published, so the library needs periodic review rather than a one-time build.

3. Why Can't the Agent Apply to Every Policy?

The agent cannot apply to every policy because it only activates for pets whose owners have voluntarily shared DNA test results.

The majority of policies will continue to rely on traditional underwriting factors alone, and the agent is designed to complement that baseline rather than assume universal genetic data availability.

4. How Does the Agent Handle Emerging or Unvalidated Markers?

The agent treats newly identified genetic markers conservatively until they accumulate enough claims-linked validation to support a pricing adjustment.

This prevents the agent from acting on a marker before there is sufficient evidence connecting it to real-world condition outcomes in the carrier's own book of business.

What Are Common Use Cases?

It is used for new policy underwriting, hereditary condition risk assessment, rate filing support, and product innovation around genetically informed coverage.

1. How Does the Agent Support New Policy Underwriting?

The agent applies genetic risk adjustments at the point of quote or policy issuance when the owner has already shared DNA test results.

This gives new policyholders who value their pet's DNA data a pricing outcome that reflects it immediately, rather than waiting for a future renewal cycle.

2. How Does the Agent Support Hereditary Condition Risk Assessment?

The agent gives underwriters a clearer view of a specific pet's hereditary condition risk profile beyond what breed alone would suggest.

This is particularly useful for mixed-breed pets, where genetic testing often reveals a risk profile that a visual breed guess would have missed entirely.

3. How Does the Agent Support Rate Filing and Product Development?

The agent's accumulated genetic-to-claims validation data gives actuarial and product teams evidence to support new rating factors or coverage tiers built around genetic risk.

This can inform new product designs, such as coverage options tailored to breeds or genetic profiles with specific hereditary condition risks.

4. How Does the Agent Support Ongoing Model Validation?

The agent continuously checks whether its genetic risk adjustments actually correlate with real claims outcomes as more data accumulates.

This ongoing validation lets actuarial teams confirm that the genetic adjustments are earning their keep in the model rather than simply adding complexity without measurable pricing benefit.

Which Questions Are Most Frequently Asked About DNA Test Integration in Underwriting?

The most frequently asked questions cover data source definition, marker mapping, consent requirements, testing providers, favorable adjustments, relationship to traditional factors, uncertain markers, and claims impact.

What is DNA test integration in pet insurance underwriting?

It is the practice of incorporating consumer pet DNA test results, such as breed composition and hereditary condition markers, into underwriting models with the owner's explicit consent.

How does the DNA Test Integration Risk Scoring AI Agent use genetic data?

It maps DNA test results to known breed-linked and hereditary condition risk factors and blends them with traditional underwriting variables to refine risk scoring for that specific pet.

Yes. The agent only processes DNA test results that the owner has explicitly opted to share, and it never requires a DNA test as a condition of coverage.

Which DNA testing providers can feed data into the agent?

The agent accepts results from major direct-to-consumer pet DNA testing providers via secure data-sharing integrations, once the owner authorizes the connection.

Can genetic risk data lower a pet's premium as well as raise it?

Yes. A DNA result that rules out a suspected hereditary risk, such as confirming a mixed breed does not carry a marker common in a purebred parent line, can support a more favorable risk score.

Does the agent replace traditional breed and age-based underwriting factors?

No. It supplements traditional factors with more precise genetic information where available, rather than replacing established underwriting variables for pets without DNA data.

How does the agent handle uncertain or inconclusive genetic markers?

It applies conservative weighting to inconclusive or low-confidence markers and never treats a single ambiguous result as decisive for a coverage or pricing decision.

How does DNA-informed underwriting affect claims outcomes?

It allows more accurate risk-based pricing for hereditary conditions, which can improve loss ratio precision and reduce cross-subsidization between lower-risk and higher-risk pets within the same breed category.

Which Sources Inform This Article?

This article draws on genetic testing market research and regulatory sources relevant to pet insurance underwriting.